Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL Meeting Abstract


Authors: Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Halton, E.; Quintanilla, H.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R. J.
Abstract Title: Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL
Meeting Title: 18th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Journal Title: Molecular Therapy
Volume: 23
Issue: Suppl. 1
Meeting Dates: 2015 May 13-16
Meeting Location: New Orleans, LA
ISSN: 1525-0016
Publisher: Nature Publishing Group  
Date Published: 2015-05-01
Start Page: S188
End Page: S189
Language: English
ACCESSION: WOS:000359951700479
PROVIDER: wos
DOI: 10.1038/mt.2015.74
Notes: Meeting Abstract: 475 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Renier J Brentjens
    286 Brentjens
  2. Kevin Joseph Curran
    144 Curran
  3. Jae Hong Park
    356 Park
  4. Craig Steven Sauter
    334 Sauter
  5. Elizabeth F Halton
    53 Halton
  6. Michel W J Sadelain
    583 Sadelain
  7. Isabelle C Riviere
    240 Riviere
  8. Xiuyan Wang
    118 Wang
  9. Yvette J Bernal
    32 Bernal